Cloning and expression of malaria and tuberculosis epitopes in Mycobacterium bovis bacille calmette-guérin

Malaysian Journal of Medical Sciences

Volumn 13, Issue 1, 2006, Pages 13-20

  Suppian, Rapeah ^a   Zainuddin, Zainul Fadziruddin ^a   Norazmi, Mohd Nor ^a  

^a SCHOOL OF HEALTH SCIENCES   (Malaysia)

Author keywords

Assembly PCR; Malaria; Multivalent vaccine; Recombinant BCG; Tuberculosis

Indexed keywords

BCG VACCINE; EPITOPE; HEAT SHOCK PROTEIN 65; MYCOBACTERIUM ANTIGEN; POLYCLONAL ANTIBODY; PROTOZOAL PROTEIN; RECOMBINANT VACCINE; SIGNAL PEPTIDE;

AMINO ACID SEQUENCE; ARTICLE; CODON USAGE; CONTROLLED STUDY; EXPRESSION VECTOR; GENE EXPRESSION; IMMUNOGENICITY; MALARIA; MOLECULAR CLONING; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PROMOTER REGION; RABBIT; SUPERNATANT; T LYMPHOCYTE; TUBERCULOSIS; WESTERN BLOTTING;

EID: 33845588747     PISSN: 1394195X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. World Health Organization. World malaria situation in 1994. Weekly Epidem Rec 1997; 72: 269-74.
2. Good MF, Kaslow DC, Miller LH. Pathway and strategies for developing a malaria blood stage vaccine. Ann Rev Immunol 1998; 16: 57-87.
3. Raghunath D. Malaria vaccine: Are we anywhere close?. J Postgrad Med 2004; 50: 51-4.
4. Phillips RS. Current status of malaria and potential for control. Clin Microbiol Rev 2001; 14: 208-26.
5. Dye D, Scheele S, Dolin P, Tathania V, Raviglione, MC. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence and mortality by country. WHO global surveillance and monitoring project. J Am Med Assoc 1999; 282: 677-86.
6. Fine PF. Variation in protection by BCG: implications of and for heterologous immunity. Lancet 1995; 346: 1339-45.
7. Flynn JL. Immunology of tuberculosis and implications in vaccine development. Tuberculosis 2004; 84: 93-101.
8. Espinal MA, Laszlo A, Simonsen L, Boulahbal F, Kim SJ, Reniero A, Hoffner S, Rieder HL, Binkin N, Dye C, Williams R, Raviglione MC. Global trends in resistance to antituberculosis drugs. World Health Organization-Intemational Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. N Engl J Med 200 1; 344: 1294-303.
9. Frieden CR, Sterling A, Pablos-Mendez J, Kilburn JO, Cauthen GM, Dooley SW. The emergence of drug-resistant tuberculosis in New York City. N Eng J Med 1993; 328: 521-6.
10. Horwitz MA, Harth G, Dillon BJ, Maslesa-Galic S. Recombinant bacillus Calmette-Guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model. Proc Natl Acad Sci USA 2000; 97: 13853-8.
11. Husson RN, James BE, Young RA. Gene replacement and expression of foreign DNA in mycobacteria. J Bacteriol 1991; 172: 519-24.
12. Stover CK, de la Cruz VF, Fuerst TR, Burlein JE, Benson LA, Benett LT, Bansal GP, Young JF, Lee MH, Hatfull GF, Snapper SB, Barletta RG, Jacobs WR Jr, Bloom BR. New use of BCG for recombinant vaccines. Nature 1991; 351: 456-60.
13. Haeseleer F, Pollet JF, Haumont M, Bollen A, Jacobs P. Stable integration and expression of the Plasmodium falciparum circurnsporozoite protein coding sequence in mycobacteria. Mol Biochem Parasitol 1993; 57: 117-26.
14. Matsumoto S, Yukitake H, Kanbara H, Yamada T. Recombinant Mycobacterium bovis bacillus Calmette-Guerin secreting merozoite surface protein 1 (MSPI) induces protection against rodent malaria parasite infection depending on MSPI-stimulated interferon gamma and parasite-specific antibodies. J Exp Med 1998; 188: 845-54.
15. Norazmi MN, Dale JW. Cloning and expression of a candidate malaria epitope in bacille Calmette Guèrin. Biotech Letters 1997; 19: 1135-7.
16. Zheng C, Xie P, Chen Y. Immune response induced by recombinant BCG expressing merozoite surface antigen 2 from Plasmodium falciparum. Vaccine 2001; 20: 914-9.
17. Abomoelak B, Huygen K, Kremer L, Turneer M, Locht C. Humoral and cellular immune responses in mice immunized with recombinant Mycobacterium bovis bacillus Calmette-Guèrin producing a pertussis toxin-tetanus toxin hybrid protein. Infect Immun 1999; 67: 5100-5.
18. Aldovini A, Young RA. Humoral and cell-mediated immune responses to live recombinant BCG-HIV vaccines. Nature 1991; 351: 479-82.
19. Norazmi MN, Zainuddin ZF, Suppian R, Dale JW. The use of assembly polymerase chain reaction for cloning of a malarial epitope into Mycobacterium smegmatis-importance of overcoming codon bias. Biotech Techn 1999; 13: 485-9.
20. Liang H, Narum DL, Fuhn-nann SR, Lau T, Sim BKL. A recombinant baculovirus-expressed Plasmodium falciparum receptor-binding domain of erythrocyte binding protein EBA-175 biologically mimics native protein. Infect Immun 2000; 68: 3564-8.
21. Sim BKL, Orlandi PA, Haynes JD, Klotz FW, Carter JM, Camus D, Zegans ME, Chulay, JD. Primary structure of the 175K Plasmodium falciparum erythrocyte binding antigen and identification of a peptide which elicits antibodies that inhibit malaria merozoite invasion. J Cell Biol 1990; 111: 1877-84.
22. Ballou WR, Hoffman SL, Sherwood JA, Hollingdale MR, Neva FA, Hockmeyer WT, Gordon DM, Schneider I, Wirtz RA, Young JF, Waserman JF, Reeve P, Diggs CL, Chulay JD. Safety and efficacy of recombinant Plasmodium falciparum sporozoite DNA vaccine. Lancet 1987; 1: 1277-81.
23. Zavala F, Cochrane AH, Nardin EH, Nussenzweig RS, Nussenzweig V. Circumsporozoite proteins of malaria parasites contain a single imunodominant region with two or more identical epitopes. J Exp Med 1983; 157: 1947-54.
24. Brandt L, Oettinger T, Holm A. Anderson AB, Anderson P. Key epitopes on the ESAT-6 antigen recognized in mice during the recall of protective immunity to Mycobacterium tuberculosis. J Immunol 1996; 157: 3527-33.
25. van Pinxteren LA, Ravn P. Agger EM, Pollock J, Anderson P. Diagnosis of tuberculosis based on the two specific antigens ESAT-6 and CFP 10. Clin Diagn Lab Immunol 2000; 7: 55-60.
26. Manca C. Lyashchenko K, Wiker HG, Usai D. Colangeli R, Gennaro MA. Molecular cloning, purification, and serological characterization of MPT63, a novel antigen secreted by Mycobacterium tuberculosis. Infect Immun 1997; 65: 16-23.
27. Nangai S, Wiker HG, Harboe M, Kinomoto M. Isolation and partial characterization of major protein antigens in the culture fluid of Mycobacterium tuberculosis. Infect Immun 1991; 59: 372-82.
28. Stemmer WPC, Crameri A, Ha KD, Brennan TM, Heynecker HL. Single-step assembly of a gene and entire plasmid from large numbers of oligodeoxyribonucleotides. Gene 1995; 164: 49-53.
29. Rao V, Dhar N, Tyagi AK. Modulation of host immune responses by overexpression of immunodominant antigens of Mycobacterium tuberculosis in bacilli Calmette-Guèrin. Scand J Immunol 2003; 58: 449-61.
30. Dale JW, Patki A. Mycobeterial gene expression and regulation. In Mcfadden J, eds. Molecular Biology of Mycobacteria. Surrey, Surrey University Press, 1990; 175-98.
31. Labidi A, David HL, Roulland-Dussoix D. Restriction endonuclease mapping and cloning of Mycobacterium fortuitum var. fortuitum plasmid pAL5000. Ann Inst Pasteur Microbial 1985; 136: 209-15.
32. Bao L, Chen W, Zhang H, Wang X. Virulence, immunogenicity and protective efficacy of two recombinant Mycobacterium bovis bacillus Calmette-Guèrin strain expressing the antigen ESAT-6 from Mycobacterium tuberculosis. Infect Immun 2003; 71: 1656-61.
33. Britton WJ, Palendira U. Improving vaccine against tuberculosis. Immunol Cell Biol 2003; 81: 34-45.
34. Whithers-Martinez C, Carpenter EP, Hackett F, Ely B, Sajid M, Grainger M, Blackman MJ. PCR-based gene synthesis as an efficient approach for expression of the A+T-rich malaria genome. Protein Engineering 1999; 12: 1113-20.
35. Narum, DL, Kumar S, Rogers WO, Fuhrmann SR, Liang H, Oakley M, Taye A, Sim BKL, Hoffman SL. Codon optimization of gene fragments encoding Plasmodium falciparum merozoite proteins enhances DNA vaccine protein expression and immunogenicity in mice. Infect Immun 2001; 69: 7250-53.